Khalid Ibrahim, D. and Akram Yahya, N. (2023) “Effects of Epigallocatechin-3-Gallate (EGCG) in Diabetes Mellitus as a DYRK1A inhibitor”, Iraqi Journal of Pharmacy, 20(2), pp. 168–173. doi: 10.33899/iphr.2023.141712.1048.